A discovery at Duke-NUS Medical School offers new
Post# of 150397
(Total Views: 386)
Posted On: 02/22/2025 5:54:11 PM
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis.
https://www.sciencedaily.com/releases/2025/02...225212.htm
"The researchers found that blocking YAP and TAZ can curb scar formation and restore the immediate environment to one that encourages regeneration"
"By focusing on the root causes of fibrosis, our novel therapeutic approach offers the potential not just to manage but to significantly halt or reverse the progression of pulmonary fibrosis. This breakthrough could dramatically improve patient outcomes, reduce long-term healthcare costs, and ultimately enhance life expectancy and quality for sufferers globally."
From other papers, CCR5 signaling supports YAP activation... so further support for leronlimab acting on the root causes of fibrosis.
"In addition to pulmonary fibrosis, YAP and TAZ are also implicated in heart, liver and kidney fibrosis, suggesting that therapies targeting these proteins could offer broader therapeutic potential for a range of fibrotic diseases." Just as Ohm already told us...
https://www.sciencedaily.com/releases/2025/02...225212.htm
"The researchers found that blocking YAP and TAZ can curb scar formation and restore the immediate environment to one that encourages regeneration"
"By focusing on the root causes of fibrosis, our novel therapeutic approach offers the potential not just to manage but to significantly halt or reverse the progression of pulmonary fibrosis. This breakthrough could dramatically improve patient outcomes, reduce long-term healthcare costs, and ultimately enhance life expectancy and quality for sufferers globally."
From other papers, CCR5 signaling supports YAP activation... so further support for leronlimab acting on the root causes of fibrosis.
"In addition to pulmonary fibrosis, YAP and TAZ are also implicated in heart, liver and kidney fibrosis, suggesting that therapies targeting these proteins could offer broader therapeutic potential for a range of fibrotic diseases." Just as Ohm already told us...
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼